Healthcare provider profile · identity verified

Nicole Bachmann

Nurse Practitioner · WOODBINE, MD · NPI 1114357993

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	338	64
Metoprolol Succinate	Metoprolol Succinate	223	36
Amlodipine Besylate	Amlodipine Besylate	203	47
Levothyroxine Sodium	Levothyroxine Sodium	202	48
Sertraline Hcl	Sertraline Hcl	184	37
Trazodone Hcl	Trazodone Hcl	179	33
Eliquis	Apixaban	169	33
Donepezil Hcl	Donepezil Hcl	166	25
Furosemide	Furosemide	155	35
Mirtazapine	Mirtazapine	135	23
Escitalopram Oxalate	Escitalopram Oxalate	126	20
Pantoprazole Sodium	Pantoprazole Sodium	117	25
Gabapentin	Gabapentin	113	28
Famotidine	Famotidine	112	21
Omeprazole	Omeprazole	109	15
Metoprolol Tartrate	Metoprolol Tartrate	108	20
Losartan Potassium	Losartan Potassium	101	20
Quetiapine Fumarate	Quetiapine Fumarate	99	19
Lisinopril	Lisinopril	98	19
Potassium Chloride	Potassium Chloride	98	24
Duloxetine Hcl	Duloxetine Hcl	91	21
Tamsulosin Hcl	Tamsulosin Hcl	89	21
Ciprofloxacin Hcl	Ciprofloxacin Hcl	81	72
Rosuvastatin Calcium	Rosuvastatin Calcium	65	suppressed
Torsemide	Torsemide	64	20
Xarelto	Rivaroxaban	63	suppressed
Pravastatin Sodium	Pravastatin Sodium	61	12
Metformin Hcl	Metformin Hcl	60	12
Memantine Hcl	Memantine Hcl	56	suppressed
Simvastatin	Simvastatin	52	suppressed
Tramadol Hcl	Tramadol Hcl	52	21
Latanoprost	Latanoprost	47	13
Levetiracetam	Levetiracetam	46	suppressed
Lorazepam	Lorazepam	46	24
Hydrochlorothiazide	Hydrochlorothiazide	45	suppressed
Olanzapine	Olanzapine	45	suppressed
Azithromycin	Azithromycin	44	37
Sucralfate	Sucralfate	44	suppressed
Fluticasone Propionate	Fluticasone Propionate	42	17
Nystatin	Nystatin	42	29
Hydralazine Hcl	Hydralazine Hcl	41	suppressed
Montelukast Sodium	Montelukast Sodium	41	suppressed
Citalopram Hbr	Citalopram Hydrobromide	39	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	38	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	36	32
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	36	31
Buspirone Hcl	Buspirone Hcl	35	suppressed
Carvedilol	Carvedilol	33	suppressed
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Valsartan	Valsartan	33	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	31	16
Folic Acid	Folic Acid	30	suppressed
Meloxicam	Meloxicam	29	suppressed
Clonazepam	Clonazepam	28	suppressed
Myrbetriq	Mirabegron	28	suppressed
Propranolol Hcl	Propranolol Hcl	28	suppressed
Risperidone	Risperidone	28	suppressed
Rybelsus	Semaglutide	28	suppressed
Lansoprazole	Lansoprazole	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	26	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Prednisone	Prednisone	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Allopurinol	Allopurinol	23	suppressed
Metformin Hcl Er	Metformin Hcl	23	suppressed
Jardiance	Empagliflozin	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Humalog Kwikpen U-100	Insulin Lispro	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	13
Linzess	Linaclotide	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	14
Ozempic	Semaglutide	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Doxepin Hcl	Doxepin Hcl	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Mupirocin	Mupirocin	18	11
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Glipizide	Glipizide	17	suppressed
Liothyronine Sodium	Liothyronine Sodium	17	suppressed
Nyamyc	Nystatin	16	suppressed
Tresiba Flextouch U-100	Insulin Degludec	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Levemir Flexpen	Insulin Detemir	15	suppressed
Methenamine Hippurate	Methenamine Hippurate	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	12
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Midodrine Hcl	Midodrine Hcl	14	suppressed
Lactulose	Lactulose	13	suppressed
Topiramate	Topiramate	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Amoxicillin-Clavulanate Pot Er	Amoxicillin/Potassium Clav	12	12
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	12	suppressed
Finasteride	Finasteride	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Zaleplon	Zaleplon	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Anastrozole	Anastrozole	11	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	11	suppressed
Cefdinir	Cefdinir	11	suppressed
Cefuroxime	Cefuroxime Axetil	11	11
Easy Touch Pen Needle	Pen Needle, Diabetic	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Rivastigmine	Rivastigmine	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error